Clinical Outcomes and Safety Profile of Vancomycin in Outpatient Parenteral Antimicrobial Therapy Services: A Systematic Review
Antibiotics · 22.06.2026 · 15 (6) · 630
DOI: 10.3390/antibiotics15060630 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 22.06.2026. Verfasst von Moska Hassanzai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Pharmacy, Erasmus MC University Medical Center, 3015 GD Rotterdam, The Netherlands. Die Arbeit nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Erasmus MC.
Abstract (Originalsprache)
Introduction
Vancomycin is a widely used antibiotic in Outpatient Parenteral Antimicrobial Therapy (OPAT) services. The objective of this systematic review was to evaluate the published literature on the efficacy and safety outcomes of outpatient vancomycin therapy.
Methods
A systematic search was performed in Embase, Medline ALL, the Web of Science Core Collection, and the Cochrane Central Register of Controlled Trials from database inception until 20 March 2026. Both randomized controlled trials and non-randomized studies published in peer-reviewed journals were included. Study quality was assessed using the Newcastle–Ottawa Scale.
Results
A total of 75 studies were included. Clinical success rates of 40.9% to 100% were reported. Reported adverse event (AE) rates ranged widely from 5.7% to 85.7%. Comparative studies suggest a higher risk of nephrotoxicity during intermittent infusion compared to continuous infusion. Reported line-related AE ranged from 1.1% to 5.7% and readmission risks associated with vancomycin use were inconsistent across studies.
Conclusions
This systematic review shows that vancomycin is an effective agent to use in OPAT setting, however its use is associated with a risk of adverse events. The findings of this study underscore the need for a dedicated multidisciplinary OPAT team to ensure proper follow-up and tailored vancomycin management in the outpatient setting.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hospital Pharmacy, Erasmus MC University Medical Center, 3015 GD Rotterdam, The Netherlands.
- Department of Clinical Pharmacy, Amphia Hospital, 4818 CK Breda, The Netherlands.
- Department of Clinical Pharmacy, Dijklander Hospital, 1624 HP Hoorn, The Netherlands.
- CATOR: Center for Antimicrobial Treatment Optimization, 3015 GD Rotterdam, The Netherlands.
- Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
- Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, 3015 GD Rotterdam, The Netherlands.
ORCID-Profile: Moska Hassanzai, Ramon R Contrucci, Nelianne J Verkaik, Hein A W van Onzenoort
Förderung
- Erasmus MC
Zitieren
APA
Hassanzai, M., Contrucci, R. R., Koch, B. C. P., Verkaik, N. J., de Winter, B. C. M., & van Onzenoort, H. A. W. (2026). Clinical Outcomes and Safety Profile of Vancomycin in Outpatient Parenteral Antimicrobial Therapy Services: A Systematic Review. Antibiotics, 15(6), 630. https://doi.org/10.3390/antibiotics15060630
Vancouver
Hassanzai M, Contrucci RR, Koch BCP, Verkaik NJ, de Winter BCM, van Onzenoort HAW. Clinical Outcomes and Safety Profile of Vancomycin in Outpatient Parenteral Antimicrobial Therapy Services: A Systematic Review. Antibiotics. 2026;15(6):630. doi:10.3390/antibiotics15060630
BibTeX
@article{Hassanzai2026,
author = {Hassanzai, Moska and Contrucci, Ramon R and Koch, Birgit C P and Verkaik, Nelianne J and de Winter, Brenda C M and van Onzenoort, Hein A W},
title = {Clinical Outcomes and Safety Profile of Vancomycin in Outpatient Parenteral Antimicrobial Therapy Services: A Systematic Review},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {6},
pages = {630},
doi = {10.3390/antibiotics15060630}
}
EUVIMED